Varicella deal helps build Takeda's vaccines presence
This article was originally published in Scrip
Executive Summary
Takeda is continuing to build up its interests in vaccines with an agreement to market in Japan a product for varicella zoster developed by Biken (the Research Foundation for Microbial Diseases of Osaka University).